Frequently Asked Questions
The market is segmented based on , By Product and Services (Services and Software), Modality (Computed Tomography, Magnetic Resonance Imaging, Echocardiography, Nuclear Medicine, Positron Emission Tomography, X-ray, Ultrasound, Optical Coherence Tomography and Others), Application (Oncology, Neurology, Endocrinology, Cardiology, Dermatology, Hematology and Others), End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Medical Device Manufacturers, Academic and Government Research Institutes and Others), Distributor (Direct Sales and Tender Sales) – Industry Trends and Forecast to 2031.
.
The Global Clinical Trial Imaging Market size was valued at USD 1.14 USD Billion in 2024.
The Global Clinical Trial Imaging Market is projected to grow at a CAGR of 8.1% during the forecast period of 2025 to 2031.
The major players operating in the market include Navitas Life Sciences, Resonance Health , BioTelemetry a Philips Company, IXICO plc, ICON plc, Image Core Lab, Anagram 4 Clinical Trials, Quotient Sciences, Radiant Sage LLC, WORLDCARE CLINICAL, Clario, Parexel International Corporation, Median Technologies, Perspectum, Calyx, Invicro LLC,.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
